Miguel Tillo

Miguel Tillo¹, 

Quenten Schwarz^1,2, 

Christiana Ruhrberg¹ 

¹UCL Institute of Ophthalmology, University College London, 

²Department of Human Immunology, Centre for Cancer Biology, South Australia